Schmidt G M, Blume K G, Bross K J, Spruce W E, Staatz C G, Turner M A
Blut. 1979 Feb 19;38(2):135-7. doi: 10.1007/BF01007954.
Lymphocyte phosphoglucomutase can be used as a genetic marker to document successful engraftment in bone marrow transplant recipients. Two patients who underwent marrow transplantation as a treatment for acute leukemia showed a change into donor-type isozyme pattern.
淋巴细胞磷酸葡萄糖变位酶可用作一种遗传标记,以证明骨髓移植受者移植成功。两名接受骨髓移植治疗急性白血病的患者显示出转变为供体类型的同工酶模式。